Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-042704
Filing Date
2021-08-16
Accepted
2021-08-16 10:21:47
Documents
10
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea145842-6k_canfitebio.htm 6-K 27528
2 OPINION OF DORON TIKOTZKY KANTOR GUTMAN, NASS & AMIT GROSS ea145842ex5-1_canfitebio.htm EX-5.1 19795
3 OPINION OF MCDERMOTT WILL & EMERY LLP ea145842ex5-2_canfitebio.htm EX-5.2 14028
4 FORM OF SECURITIES PURCHASE AGREEMENT DATED AS OF AUGUST 11, 2021 BETWEEN CAN-FI ea145842ex10-1_canfitebio.htm EX-10.1 212757
5 FORM OF PRE-FUNDED WARRANT TO BE ISSUED BY CAN-FITE BIOPHARMA LTD. ON AUGUST 16, ea145842ex10-2_canfitebio.htm EX-10.2 99204
6 FORM OF WARRANT TO BE ISSUED BY CAN-FITE BIOPHARMA LTD. ON AUGUST 16, 2021 ea145842ex10-3_canfitebio.htm EX-10.3 102314
7 FORM OF PLACEMENT AGENT WARRANT TO BE ISSUED BY CAN-FITE BIOPHARMA LTD. ON AUGUS ea145842ex10-4_canfitebio.htm EX-10.4 102658
8 GRAPHIC ex5-1_001.jpg GRAPHIC 27219
9 GRAPHIC ex5-2_001.jpg GRAPHIC 18063
10 GRAPHIC ex5-2_002.jpg GRAPHIC 3077
  Complete submission text file 0001213900-21-042704.txt   646368
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 211175198
SIC: 2834 Pharmaceutical Preparations